• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在无明确食管炎的患者中使用奥美拉唑缓解反流症状。

Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis.

作者信息

Bate C M, Griffin S M, Keeling P W, Axon A T, Dronfield M W, Chapman R W, O'Donoghue D, Calam J, Crowe J, Mountfords R A, Watts D A, Taylor M D, Richardson P D

机构信息

Royal Albert Edward Infirmary, Wigan, UK.

出版信息

Aliment Pharmacol Ther. 1996 Aug;10(4):547-55. doi: 10.1046/j.1365-2036.1996.44186000.x.

DOI:10.1046/j.1365-2036.1996.44186000.x
PMID:8853758
Abstract

BACKGROUND

As many as 50% of patients with reflux symptoms have no endoscopic evidence of oesophagitis. This multicentre study was designed to assess symptom relief after omeprazole 20 mg once daily in patients with symptoms typical of gastro-oesophageal reflux disease but without endoscopic evidence of oesophagitis.

METHODS

Patients (n = 209) were randomized in a double-blind study to receive either omeprazole 20 mg once daily (n = 98) or placebo (n = 111) for 4 weeks. Symptoms were assessed at clinic visits and using daily diary cards, with patient-completed questionnaires providing additional data on symptoms and on psychological disturbance.

RESULTS

On completion, symptom relief favoured omeprazole: 57% of patients on omeprazole were free of heartburn (vs. 19% on placebo), 75% were free of regurgitation (47%) and 43% were completely asymptomatic (14%), each with P < 0.0001. Fewer patients in the omeprazole group required alginate/antacid relief medication (P < 0.05). Symptom relief (time to first heartburn-free day) was more rapid with omeprazole (2 vs. 5 days on placebo; P < 0.01). A greater reduction in anxiety occurred in the omeprazole group (P < 0.05).

CONCLUSION

Omeprazole 20 mg once daily is effective in providing relief of the symptoms typical of gastro-oesophageal reflux disease in patients with essentially normal oesophageal mucosa.

摘要

背景

多达50%有反流症状的患者没有食管炎的内镜检查证据。这项多中心研究旨在评估每日一次服用20毫克奥美拉唑对有胃食管反流病典型症状但无食管炎内镜检查证据的患者的症状缓解情况。

方法

在一项双盲研究中,将209例患者随机分为两组,一组每日一次服用20毫克奥美拉唑(98例),另一组服用安慰剂(111例),为期4周。在门诊就诊时和使用每日日记卡评估症状,患者填写的问卷提供了关于症状和心理障碍的额外数据。

结果

研究结束时,症状缓解情况有利于奥美拉唑组:服用奥美拉唑的患者中,57%无烧心症状(安慰剂组为19%),75%无反流症状(安慰剂组为47%),43%完全无症状(安慰剂组为14%),各项均P<0.0001。奥美拉唑组需要藻酸盐/抗酸缓解药物的患者较少(P<0.05)。奥美拉唑组症状缓解(至首个无烧心日的时间)更快(奥美拉唑组为2天,安慰剂组为5天;P<0.01)。奥美拉唑组焦虑程度降低更明显(P<0.05)。

结论

对于食管黏膜基本正常的患者,每日一次服用20毫克奥美拉唑可有效缓解胃食管反流病的典型症状。

相似文献

1
Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis.在无明确食管炎的患者中使用奥美拉唑缓解反流症状。
Aliment Pharmacol Ther. 1996 Aug;10(4):547-55. doi: 10.1046/j.1365-2036.1996.44186000.x.
2
Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis.无论有无内镜下食管炎,奥美拉唑在缓解各级胃食管反流病相关烧心方面比西咪替丁更有效。
Aliment Pharmacol Ther. 1997 Aug;11(4):755-63. doi: 10.1046/j.1365-2036.1997.00198.x.
3
Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.雷贝拉唑在治疗糜烂性胃食管反流病方面与奥美拉唑等效。一项关于雷贝拉唑和20毫克奥美拉唑治疗反流性食管炎急性发作的随机、双盲、对照研究,随后采用雷贝拉唑进行维持期开放标签低剂量治疗。
Dig Liver Dis. 2005 Oct;37(10):741-50. doi: 10.1016/j.dld.2005.04.026.
4
Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group.基层医疗中的胃食管反流病:一项关于奥美拉唑不同治疗策略的国际研究。国际胃食管反流病研究组
Eur J Gastroenterol Hepatol. 1998 Feb;10(2):119-24.
5
Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease.
J Gastroenterol Hepatol. 1996 Oct;11(10):900-2. doi: 10.1111/j.1440-1746.1996.tb00269.x.
6
Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.奥美拉唑10毫克每日一次、奥美拉唑20毫克每日一次或雷尼替丁150毫克每日两次,作为全科医疗中缓解胃食管反流病症状的初始治疗方案进行评估。
Scand J Gastroenterol. 1997 Oct;32(10):965-73. doi: 10.3109/00365529709011211.
7
A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease.标准剂量雷贝拉唑与高剂量奥美拉唑治疗胃食管反流病的随机、双盲、对照研究
Aliment Pharmacol Ther. 2002 Mar;16(3):479-85. doi: 10.1046/j.1365-2036.2002.01207.x.
8
Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.胃食管反流病的症状缓解:泮托拉唑与尼扎替丁在患有糜烂性食管炎或内镜检查阴性反流病的混合患者群体中的随机对照比较。
Am J Gastroenterol. 2001 Oct;96(10):2849-57. doi: 10.1111/j.1572-0241.2001.4237_a.x.
9
Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring.通过内镜检查、组织学检查以及24小时pH监测,对奥美拉唑(每日40毫克)与西咪替丁(每日400毫克)治疗有症状的糜烂性反流性食管炎进行双盲比较。
Gut. 1990 May;31(5):509-13. doi: 10.1136/gut.31.5.509.
10
Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole.反流性食管炎症状的快速缓解:兰索拉唑与奥美拉唑的比较
Aliment Pharmacol Ther. 1996 Oct;10(5):757-63. doi: 10.1046/j.1365-2036.1996.56198000.x.

引用本文的文献

1
Risk factors associated with functional esophageal disorders (FED) versus gastroesophageal reflux disease (GERD).与功能性食管疾病(FED)相关的风险因素与胃食管反流病(GERD)。
Surg Endosc. 2024 May;38(5):2842-2849. doi: 10.1007/s00464-024-10714-0. Epub 2024 Mar 25.
2
Evaluation of the Efficacy and Safety of DW1903 in Patients with Gastritis: A Randomized, Double-Blind, Noninferiority, Multicenter, Phase 3 study.DW1903 治疗胃炎有效性和安全性的评价:一项随机、双盲、非劣效、多中心、3 期研究。
Gut Liver. 2024 Jan 15;18(1):70-76. doi: 10.5009/gnl220446. Epub 2023 Jun 13.
3
An Evidence-Based Retrospective Study for the Management of Acid Peptic Disease With Omeprazole, a Proton Pump Inhibitor, in Indian Patients With Type 2 Diabetes Mellitus (PRIDE-1).
一项基于证据的回顾性研究:在印度2型糖尿病患者中使用质子泵抑制剂奥美拉唑治疗酸相关性疾病(PRIDE-1)
Cureus. 2022 Dec 8;14(12):e32332. doi: 10.7759/cureus.32332. eCollection 2022 Dec.
4
Comparison of acid-lowering drugs for endoscopy negative reflux disease: Systematic review and network Meta-Analysis.内镜阴性反流病抑酸药物治疗的比较:系统评价和网络荟萃分析。
Neurogastroenterol Motil. 2023 Jan;35(1):e14469. doi: 10.1111/nmo.14469. Epub 2022 Sep 25.
5
Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study.在非糜烂性反流病患者中,AlbisD与20毫克奥美拉唑相比的疗效和安全性:一项随机、开放标签、活性对照的试点研究。
J Neurogastroenterol Motil. 2019 Jul 1;25(3):403-412. doi: 10.5056/jnm18185.
6
The Clinical Efficacy of a Pure Alginate Formulation (Lamina G) for Controlling Symptoms in Individuals with Reflux Symptoms: A Randomized Clinical Study.一种纯藻酸盐配方(Lamina G)控制反流症状个体症状的临床疗效:一项随机临床研究。
Gut Liver. 2019 Nov 15;13(6):642-648. doi: 10.5009/gnl18378.
7
Adult and paediatric GERD: diagnosis, phenotypes and avoidance of excess treatments.成人和儿科胃食管反流病:诊断、表型和避免过度治疗。
Nat Rev Gastroenterol Hepatol. 2016 Sep;13(9):529-42. doi: 10.1038/nrgastro.2016.109. Epub 2016 Jul 27.
8
Current advances in the diagnosis and treatment of nonerosive reflux disease.非糜烂性反流病的诊断和治疗的最新进展。
Gastroenterol Res Pract. 2013;2013:653989. doi: 10.1155/2013/653989. Epub 2013 Jul 11.
9
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.使用质子泵抑制剂、H2受体拮抗剂和促动力药对胃食管反流病样症状及内镜检查阴性的反流病进行短期治疗。
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD002095. doi: 10.1002/14651858.CD002095.pub5.
10
Acid peptic diseases: pharmacological approach to treatment.酸相关性疾病:治疗的药理学方法
Expert Rev Clin Pharmacol. 2009 May;2(3):295-314. doi: 10.1586/ecp.09.8.